Man Group’s Blueprint Medicines BPMC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-516,258
| Closed | -$66.2M | – | 2226 |
|
|
2025
Q2 | $66.2M | Sell |
516,258
-3,479
| -0.7% | -$361K | 0.13% | 174 |
|
|
2025
Q1 | $46M | Buy |
519,737
+415,818
| +400% | +$40.6M | 0.12% | 210 |
|
|
2024
Q4 | $9.06M | Sell |
103,919
-414,697
| -80% | -$38M | 0.02% | 763 |
|
|
2024
Q3 | $48M | Buy |
518,616
+125,718
| +32% | +$12.5M | 0.12% | 199 |
|
|
2024
Q2 | $42.3M | Sell |
392,898
-15,982
| -4% | -$1.6M | 0.11% | 214 |
|
|
2024
Q1 | $38.8M | Buy |
408,880
+30,816
| +8% | +$2.64M | 0.1% | 231 |
|
|
2023
Q4 | $34.9M | Buy |
+378,064
| New | +$24.5M | 0.1% | 239 |
|
|
2023
Q1 | – | Sell |
-6,911
| Closed | -$311K | – | 749 |
|
|
2022
Q4 | $303K | Sell |
6,911
-35,629
| -84% | -$1.71M | ﹤0.01% | 1647 |
|
|
2022
Q3 | $2.8M | Buy |
+42,540
| New | +$2.73M | 0.01% | 951 |
|
|
2022
Q1 | – | Sell |
-42,797
| Closed | -$4.58M | – | 2187 |
|
|
2021
Q4 | $4.58M | Sell |
42,797
-17,238
| -29% | -$1.8M | 0.01% | 905 |
|
|
2021
Q3 | $6.17M | Sell |
60,035
-558
| -0.9% | -$52K | 0.02% | 758 |
|
|
2021
Q2 | $5.33M | Buy |
60,593
+45,847
| +311% | +$4.2M | 0.02% | 856 |
|
|
2021
Q1 | $1.43M | Sell |
14,746
-54,067
| -79% | -$5.4M | 0.01% | 1206 |
|
|
2020
Q4 | $7.72M | Sell |
68,813
-21,186
| -24% | -$2.23M | 0.03% | 561 |
|
|
2020
Q3 | $8.34M | Sell |
89,999
-22,233
| -20% | -$1.71M | 0.03% | 553 |
|
|
2020
Q2 | $8.75M | Buy |
112,232
+33,880
| +43% | +$2.29M | 0.04% | 406 |
|
|
2020
Q1 | $4.58M | Buy |
78,352
+50,915
| +186% | +$3.28M | 0.03% | 527 |
|
|
2019
Q4 | $2.2M | Sell |
27,437
-16,758
| -38% | -$1.25M | 0.01% | 1305 |
|
|
2019
Q3 | $3.25M | Sell |
44,195
-8,801
| -17% | -$761K | 0.01% | 1072 |
|
|
2019
Q2 | $5M | Buy |
52,996
+42,147
| +388% | +$3.48M | 0.02% | 950 |
|
|
2019
Q1 | $868K | Buy |
10,849
+4,314
| +66% | +$319K | ﹤0.01% | 1618 |
|
|
2018
Q4 | $352K | Sell |
6,535
-12,370
| -65% | -$752K | ﹤0.01% | 1692 |
|
|
2018
Q3 | $1.48M | Sell |
18,905
-39,676
| -68% | -$2.76M | 0.01% | 1521 |
|
|
2018
Q2 | $3.72M | Buy |
+58,581
| New | +$4.66M | 0.02% | 1087 |
|
Other funds holding BPMC
IA
HNB
Man Group's BPMC Position: Q3 2025 in Review
Man Group sold out of Blueprint Medicines (BPMC) in Q3 2025, closing a stake of 516,258 shares — an estimated $66.2M sold.
Man Group first reported a position in BPMC in Q2 2018 and held it in 24 quarters. The position peaked at $66.2M in Q2 2025. 5 funds tracked by Wall St. Rank hold BPMC as of Q3 2025.
- Man Group reported no remaining Blueprint Medicines position as of Q3 2025 after selling out during the quarter.
- Man Group sold 516,258 Blueprint Medicines shares in Q3 2025, an estimated $66.2M.
- Man Group first reported a position in Blueprint Medicines in Q2 2018 and held it in 24 quarters.
- Man Group's Blueprint Medicines position peaked at $66.2M in Q2 2025.
- 5 funds tracked by Wall St. Rank held Blueprint Medicines as of Q3 2025.
Based on Man Group's 13F filing for Q3 2025, filed 14 Nov 2025.